Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Research of Integrated Traditional Chinese and Western Medicine on Precocious Puberty
NCT07325903Phase 1Withdrawn
- Sponsor
- Children's Hospital of Fudan University
- Start
- May 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Sanghe Jianghuo Granules in precocious puberty (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: Breast Tanner Stages at 3 months. Planned start May 2026; status: withdrawn.
02
Drugs
Sanghe Jianghuo Granules
03
Conditions
precocious puberty
Beyond the preview
Go deeper on NCT07325903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07325903.